Blueprint Medicines Corp (BPMC)
94.90
+3.51
(+3.84%)
USD |
NASDAQ |
May 01, 16:00
94.90
0.00 (0.00%)
After-Hours: 20:00
Blueprint Medicines Total Return Price: 94.90 for May 1, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 30, 2024 | 91.39 |
April 29, 2024 | 93.10 |
April 26, 2024 | 93.00 |
April 25, 2024 | 90.73 |
April 24, 2024 | 92.26 |
April 23, 2024 | 92.29 |
April 22, 2024 | 90.61 |
April 19, 2024 | 86.85 |
April 18, 2024 | 88.90 |
April 17, 2024 | 88.38 |
April 16, 2024 | 86.09 |
April 15, 2024 | 85.18 |
April 12, 2024 | 87.25 |
April 11, 2024 | 92.25 |
April 10, 2024 | 90.49 |
April 09, 2024 | 92.20 |
April 08, 2024 | 91.54 |
April 05, 2024 | 91.65 |
April 04, 2024 | 90.68 |
April 03, 2024 | 92.23 |
April 02, 2024 | 91.56 |
April 01, 2024 | 96.42 |
March 28, 2024 | 94.86 |
March 27, 2024 | 94.79 |
March 26, 2024 | 89.67 |
Date | Value |
---|---|
March 25, 2024 | 88.22 |
March 22, 2024 | 87.04 |
March 21, 2024 | 90.05 |
March 20, 2024 | 88.26 |
March 19, 2024 | 87.97 |
March 18, 2024 | 86.82 |
March 15, 2024 | 90.50 |
March 14, 2024 | 87.71 |
March 13, 2024 | 90.60 |
March 12, 2024 | 89.70 |
March 11, 2024 | 89.47 |
March 08, 2024 | 92.30 |
March 07, 2024 | 92.04 |
March 06, 2024 | 90.38 |
March 05, 2024 | 89.67 |
March 04, 2024 | 90.80 |
March 01, 2024 | 95.12 |
February 29, 2024 | 93.52 |
February 28, 2024 | 95.45 |
February 27, 2024 | 99.79 |
February 26, 2024 | 95.05 |
February 23, 2024 | 89.49 |
February 22, 2024 | 86.00 |
February 21, 2024 | 87.26 |
February 20, 2024 | 91.25 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
37.97
Minimum
Feb 24 2023
124.48
Maximum
Dec 23 2020
74.96
Average
74.88
Median
Aug 24 2022
Total Return Price Benchmarks
Alnylam Pharmaceuticals Inc | 149.93 |
Apellis Pharmaceuticals Inc | 46.07 |
Ionis Pharmaceuticals Inc | 43.00 |
Madrigal Pharmaceuticals Inc | 210.82 |
Sarepta Therapeutics Inc | 130.99 |